QTTB Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
0
0
0
-100.0%
53.7M
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
-100.0%
53.7M
0
Operating Expenses
10.7M
+16.9%
9.1M
+18.1%
7.7M
-1.7%
7.9M
+3.7%
7.6M
R&D
5.1M
+20.9%
4.3M
+32.3%
3.2M
-2.9%
3.3M
-6.8%
3.6M
SG&A
5.5M
+13.4%
4.9M
+7.9%
4.5M
-0.9%
4.5M
+13.0%
4.0M
Operating Income
-10660000
-16.9%
-9118000
-18.1%
-7722000
-116.8%
45.9M
+705.5%
-7577000
EBITDA
-10576000
-17.1%
-9033000
-18.4%
-7632000
-116.6%
46.0M
+714.1%
-7486000
Net Income
-8922000
+0.3%
-8946000
-17.6%
-7609000
-113.2%
57.7M
+881.3%
-7389000
EPS (Basic)
$-0.26
+40.9%
$-0.44
+18.5%
$-0.54
-111.8%
$4.59
+865.0%
$-0.60
EPS (Diluted)
$-0.26
+40.9%
$-0.44
+18.5%
$-0.54
-111.8%
$4.57
+861.7%
$-0.60
Shares (Diluted)
34.0M
+67.3%
20.3M
+44.3%
14.1M
+11.7%
12.6M
+3.1%
12.2M
Q32 Bio (QTTB) — Financials